Laboratory of Chemical Biology, Institute of Biochemistry, Biological Research Centre, 62 Temesvári krt., H-6726 Szeged, Hungary.
Theoretical Medicine Doctoral School, Faculty of Medicine, University of Szeged, 97 Tisza L. krt., H-6722 Szeged, Hungary.
Int J Mol Sci. 2023 Feb 20;24(4):4232. doi: 10.3390/ijms24044232.
The type I cannabinoid G protein-coupled receptor (CB1, GPCR) is an intensely investigated pharmacological target, owing to its involvement in numerous physiological functions as well as pathological processes such as cancers, neurodegenerative diseases, metabolic disorders and neuropathic pain. In order to develop modern medications that exert their effects through binding to the CB1 receptor, it is essential to understand the structural mechanism of activation of this protein. The pool of atomic resolution experimental structures of GPCRs has been expanding rapidly in the past decade, providing invaluable information about the function of these receptors. According to the current state of the art, the activity of GPCRs involves structurally distinct, dynamically interconverting functional states and the activation is controlled by a cascade of interconnecting conformational switches in the transmembrane domain. A current challenge is to uncover how different functional states are activated and what specific ligand properties are responsible for the selectivity towards those different functional states. Our recent studies of the μ-opioid and β-adrenergic receptors (MOP and βAR, respectively) revealed that the orthosteric binding pockets and the intracellular surfaces of these receptors are connected through a channel of highly conserved polar amino acids whose dynamic motions are in high correlation in the agonist- and G protein-bound active states. This and independent literature data led us to hypothesize that, in addition to consecutive conformational transitions, a shift of macroscopic polarization takes place in the transmembrane domain, which is furnished by the rearrangement of polar species through their concerted movements. Here, we examined the CB1 receptor signaling complexes utilizing microsecond scale, all-atom molecular dynamics (MD) simulations in order to see if our previous assumptions could be applied to the CB1 receptor too. Apart from the identification of the previously proposed general features of the activation mechanism, several specific properties of the CB1 have been indicated that could possibly be associated with the signaling profile of this receptor.
I 型大麻素 G 蛋白偶联受体 (CB1,GPCR) 是一个备受关注的药理学靶点,因为它参与了许多生理功能以及癌症、神经退行性疾病、代谢紊乱和神经性疼痛等病理过程。为了开发通过与 CB1 受体结合发挥作用的现代药物,了解这种蛋白质的激活结构机制至关重要。在过去的十年中,GPCR 的原子分辨率实验结构库迅速扩大,为这些受体的功能提供了宝贵的信息。根据目前的技术水平,GPCR 的活性涉及结构上不同的、动态相互转化的功能状态,并且激活受跨膜域中相互连接的构象开关级联的控制。目前的挑战是揭示不同的功能状态如何被激活,以及特定的配体特性如何导致对这些不同功能状态的选择性。我们最近对 μ-阿片和 β-肾上腺素能受体 (MOP 和 βAR) 的研究表明,这些受体的变构结合口袋和细胞内表面通过一个高度保守的极性氨基酸通道连接,其在激动剂和 G 蛋白结合的活性状态下的动态运动高度相关。这一发现和独立的文献数据使我们假设,除了连续的构象转变之外,跨膜域中还会发生宏观极化的转移,这是通过它们的协同运动来重新排列极性物质来实现的。在这里,我们利用微秒尺度的全原子分子动力学 (MD) 模拟研究了 CB1 受体信号复合物,以确定我们之前的假设是否也可以应用于 CB1 受体。除了确定之前提出的激活机制的一般特征外,还指出了 CB1 的几个特定性质,这些性质可能与该受体的信号转导特征有关。